Your browser doesn't support javascript.
loading
Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
Powell Doherty, Rebecca D; Liao, Hanqing; Satsangi, Jack J; Ternette, Nicola.
Afiliação
  • Powell Doherty RD; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Liao H; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Satsangi JJ; Translational Gastroenterology Unit, Experimental Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Ternette N; Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: nicola.ternette@ndm.ox.ac.uk.
Gastroenterology ; 159(2): 784-787, 2020 08.
Article em En | MEDLINE | ID: mdl-32275970
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Haplótipos / Doença de Crohn / Anticorpos Anti-Idiotípicos / Cadeias alfa de HLA-DQ / Adalimumab / Infliximab / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Haplótipos / Doença de Crohn / Anticorpos Anti-Idiotípicos / Cadeias alfa de HLA-DQ / Adalimumab / Infliximab / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2020 Tipo de documento: Article